Applied DNA Sciences (APDN) Jumps 50% Amid FDA Approves EUA Amendment

So many times Applied DNA Sciences (NASDAQ: APDN) struggled to cross $10 after the steep fall in September 2019. Entering the race of developing the COVID-19 vaccine could lift its shares near $11 but suddenly fell as other biotech companies are informing about their successes very often.

Today in APDN rose 34.56% quicky after informing FDA permits to use diagnostic kit testing capacity through the use of automated RNA extraction to treat the COVID-19 victim. Soon the demand for its shares may lift the daily volume.

Even though APDN has negative earnings short term trading investors could take a huge advantage of its rising shares. Speculation around COVID-19 may deliver a chance to soar higher.

Alex Krakowsky

Editor in Chief. Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life